NCT06214858View on ClinicalTrials.gov

The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

April 2, 2024

Study Completion Date

April 30, 2024

Conditions
Phase 1
Interventions
DRUG

SHEN211 tablets

SHEN211 tablets, tablets, specification: 0.11g, 10 tablets/box, storage: sealed, not more than 25℃ storage.

DRUG

SHEN211 placebo tablets

placebo tablets, tablets, specification: 0g, 10 tablets/box, storage: sealed, not more than 25℃ storage.

Trial Locations (1)

250014

RECRUITING

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province), Jinan

All Listed Sponsors
lead

JKT Biopharma Co., Ltd.

INDUSTRY